You are here

Ibrance Real World Insights [IRIS]

Last updated on February 28, 2019

FOR MORE INFORMATION
Study Location
Pfizer, Inc.
New York, New York, 10017 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Malignant Neoplasm of Breast
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- ≥18 years old

- HR+/HER2- breast cancer diagnosis with confirmed metastatic or advanced disease.

- Received palbociclib plus letrozole/aromatase inhibitor or palbociclib plus
fulvestrant in line with the licenced indication(s)

- No prior or current enrolment in an interventional clinical trial for ABC/MBC

- Minimum of three months of follow up data since palbociclib with fulvestrant
initiation, or minimum of six months of follow up data since palbociclib with
letrozole/aromatase inhibitor initiation (core medical record review)

- Minimum of three months of follow up data since palbociclib initiation (interim
medical record review)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- ≥18 years old

- HR+/HER2- breast cancer diagnosis with confirmed metastatic or advanced disease.

- Received palbociclib plus letrozole/aromatase inhibitor or palbociclib plus
fulvestrant in line with the licenced indication(s)

- No prior or current enrolment in an interventional clinical trial for ABC/MBC

- Minimum of three months of follow up data since palbociclib with fulvestrant
initiation, or minimum of six months of follow up data since palbociclib with
letrozole/aromatase inhibitor initiation (core medical record review)

- Minimum of three months of follow up data since palbociclib initiation (interim
medical record review)

NCT03159195
Pfizer
Recruiting
Ibrance Real World Insights [IRIS]

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Malignant Neoplasm of Breast
NCT03159195
Females
18+
Years
New York, New York

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now